Cancer immunotherapy, which uses drugs that stimulate the body's immune cells to attack tumors, is a promising approach to ...

Multimodality Therapy for Locally Advanced Cervical Carcinoma: State of the Art and Future Directions We reviewed the current evidence on the clinical management of these relatively rare ovarian ...

Northwestern Medicine scientists have discovered how a specific transcription factor promotes genetic reprogramming and ...

Adelaide researchers have identified a promising new biomarker and treatment target for ovarian cancer that could markedly ...

Nanoparticles carrying IL-12 are non-toxic, elicit strong systemic antitumor immunity, and sensitize ovarian tumors to ICI therapy, a new study shows.

Results of a study led by researchers at Roswell Park Comprehensive Cancer Center show that combining two types of immunotherapy—engineered T cells that secrete bispecific T cell engagers (BiTEs) and ...

Prior research on the potential role of cytokines found that IL-6 signaling can reprogram and alter T-cell immune responses ...

High-risk MSCs (yellow) are more abundant in fallopian tubes from patients with STIC lesions (bottom) compared to those without these lesions (top). Researchers at the University of Pittsburgh have ...

University of Galway have made a breakthrough in understanding the body’s response to bowel cancer, opening up new treatment possibilities for people.